Please login to the form below

Not currently logged in
Email:
Password:

Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Adil-Zainulbhai-Cipla

India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director.

A native of India Zainulbhai moved to the US in 1979 to join consulting firm McKinsey & Company. He returned to Mumbai in 2004 to help grow the company's presence in India, working with CEOs of many of the country's largest firms across several industries.

Cipla chairman Y K Hamied said: "Adil's 30 plus years of experience across various industries in India and globally will add a valuable perspective to our board of directors."

Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to the world while building a strong company. I look forward to helping Cipla become even more successful."

29th July 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics